This Month in the Journal  by Beauregard, Kathryn
Am. J. Hum. Genet. 69:i–ii, 2001
i
This Month in the Journal
As Jost Scho¨nberger and Christine Seidman describe in
a review this issue (p. 249), there are many genetic
loci—and many nongenetic etiologies—that are associ-
ated with dilated cardiomyopathy. Knowing the genes
that are associated with dilated cardiomyopathy has al-
lowed the identification and treatment of presympto-
matic individuals in affected families, thereby reducing
the symptoms and decreasing the morbidity and mor-
tality of the disease. The genetic studies also give us a
better understanding of the heart’s action, as well as
ways in which it can fail. This review article gives an
overview of the genetic loci that are associated with di-
lated cardiomyopathy and of the mechanisms by which
mutations are thought to lead to this disorder.
HAC-Mediated Rescue of HPRT Deficiency, by Mejı´a
et al. (p. 315)
Mejı´a et al. have developed a human artificial chromo-
some (HAC) that is composed of centromeric sequences
from chromosome 17, telomeric sequences, and a chro-
mosome Xq26.1 segment containing the hypoxanthine
phosphoribosyltransferase (HPRT) gene. Transfection of
the HAC into HPRT HT1080 fibrosarcoma cells result-
ed in relatively stable complementation of the HPRT de-
fect of the cells. The HAC appears to be maintained as
a minichromosome, although a low level of integration
was detected in some cell lines. Structural characterization
of the HACs in a few clones indicates that they consist
of irregular, alternating segments of alphoid and nonal-
phoid DNA that were derived only from the input DNA.
This system should be helpful in future studies of the
generation and maintenance of de novo centromeres, but
it also has potential as a gene-therapy vector.
Sequence Variation in TCRB V Genes, by
Subrahmanyan et al. (p. 381)
The TCRB locus is a gene cluster, on chromosome 7, that
encodes the b subunit of the T-cell antigen receptor. It is
an interesting locus for association studies of disease sus-
ceptibility and of autoimmune disease, but a detailed char-
acterization of polymorphisms in this locus, for use in
these studies, had not been performed until the study by
Subrahmanyan et al. In four populations, they sequenced
63 of 65 variable (V) segments inTCRB.Using these data,
they generated one of the densest single-nucleotide poly-
morphism (SNP) maps to date, with approximately one
SNP every 200 bp. Within exonic sequences, 74% of the
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variation identified was nonsynonymous. This is higher
than has been seen in other surveys of human genetic
diversity, but it is very close to the proportion (76%) of
nonsynonymous changes predicted in the absence of any
selection. Furthermore, the frequency spectrum of non-
synonymous changes at the locus did not deviate from
neutrality. These data are consistent with the idea that
TCRB diversity has been generated through a neutral ev-
olutionary process. Another thing that may be surprising
to readers concerns the finding that, across the TCRB
locus, there are clusters of adjacent polymorphisms that
are in strong linkage disequilibrium (LD) with each other.
These clusters of LD could suggest local depressions in
recombination rate or that the spaces between these clus-
ters are hotspots of recombination. However, simulations
under a neutral model with uniform rates of mutation
and of recombination indicate that similar blocks of LD
can be generated without these forces, meaning that the
clusters could have been generated by the chance occur-
rence of a low level of local recombination.
Schizophrenia and Translocation t(1;11) (Report), by
Blackwood et al. (p. 428)
Blackwood et al. describe a family that carries a balanced
translocation, t(1;11)(q42.1;q14.3), that is linked to
schizophrenia and affective disorders. Diagnoses that ap-
pear to be associated with the translocation include
schizophrenia, bipolar disorder, recurrent major depres-
sion, and minor depression. A maximum LOD score of
7.1 was seen between the translocation and a phenotype
that included schizophrenia, bipolar disorder, and re-
current major depression. This is certainly very strong
evidence for linkage with a psychiatric disorder. The in-
volvement of the 1q42 region in the phenotype is further
supported by genome scans, for schizophrenia and bi-
polar disorder, that have achieved suggestive and sig-
nificant LOD scores with markers in regions near the
translocation breakpoint. Prolonged latency and re-
duced amplitude of auditory P300 event–related poten-
tial have been documented in both affected and unaf-
fected members of families with schizophrenia. In this
work, Blackwood et al. demonstrate that these measures
of P300 amplitude and latency are altered in translo-
cation carriers—as opposed to noncarriers—regardless
of whether they are affected. This finding supports the
idea that P300 measures are markers of risk for these
disorders. Two genes, DISC1 and DISC2, are directly
disrupted by the translocation and are candidate genes
for a role in these psychiatric disorders.
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Maternal Folate Polymorphisms (Report), by Hassold
et al. (p. 434)
The purported link between trisomy 21 and polymor-
phisms in the genes for methylenetetrahydrofolate re-
ductase (MTHFR) and methionine synthase reductase
(MTRR) was the first evidence for a genetic underpin-
ning to chromosomal segregation abnormalities. Given
the role of MTHFR and MTRR in folate metabolism,
this finding brought the suggestion that nutritional pre-
vention strategies might be employed to reduce nondis-
junction, which is an intriguing idea. Hassold et al. have
gathered samples to determine whether any associations
exist between these genes and cases of trisomy of chro-
mosomes other than 21. They genotyped the maternal
MTHFR and MTRR polymorphisms in trisomy cases
that were known to be of maternal origin. Sex-chro-
mosome and some autosomal trisomies were studied. A
significant increase in the T allele at position 677 of
MTHFR in mothers of trisomy 18 conceptuses was the
only allele-frequency difference that was detected be-
tween cases and controls. These results do not provide
much support for a major effect of maternal MTHFR
and MTRR polymorphisms on meiotic nondisjunction.
As the authors explain, several confounding factors may
explain the discrepancy between their results and those
reported for trisomy 21. Further studies of the associ-
ation between MTHFR, MTRR, and meiotic nondis-
junction are certainly warranted.
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